Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Thyroid hormone T3
Control Group
Locations
2
United States
Emory University Hospital (EUH)
Atlanta, Georgia, United States
Emory University Hospital Clinical Research Network
Atlanta, Georgia, United States
Start Date
December 2, 2022
Primary Completion Date
May 1, 2026
Completion Date
May 1, 2026
Last Updated
June 26, 2025
NCT07083011
NCT07037459
NCT07550790
NCT06148935
NCT06874556
NCT06741436
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions